Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
NCT00026754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19522
Last updated 2025-04-18
Summary
The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical program may include screening studies that are not medically necessary for disease management, but are done purely for research purposes.
Patients with a known or suspected diagnosis of cancer, HIV infection, skin disorder or immunodeficiency who are being considered for enrollment in a National Cancer Institute intramural clinical research protocol will participate in this consent protocol. It informs patients of screening tests and procedures involving minimal risk that are done for research purposes only, including blood tests, electrocardiogram, standard X-rays (e.g., chest X-ray), bone films, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine studies. It explains that other eligibility screens that are more invasive and involve greater risk, such as a biopsy, will require separate consent.
...
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
James L Gulley, M.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-01-14
- Primary Completion
- 2024-11-29
- Completion
- 2024-11-29
Countries
- United States
Study Locations
More Related Trials
-
Data Collection, Clinical Care and Interventions in CCR, NCI
NCT00923065 ·Status: ENROLLING_BY_INVITATION
-
Clinical Genetics Branch Eligibility Screening Survey
NCT07005297 ·Status: NOT_YET_RECRUITING
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Optional Sub-study to Intraoperative Imaging With ICG Registry
NCT02651246 ·Status: COMPLETED
-
Role of Gut Microbiome in Cancer Therapy
NCT05112614 ·Status: RECRUITING
-
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
NCT02706652 ·Status: TERMINATED
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
NCT02682667 ·Status: RECRUITING
-
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
NCT01365949 ·Status: COMPLETED
-
Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors
NCT02092714 ·Status: UNKNOWN
-
Validation of MMS Test for Cancer Monitoring
NCT02113683 ·Status: TERMINATED
-
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
NCT01117168 ·Status: ACTIVE_NOT_RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Community Cancer Centers Pilot Patient Survey
NCT00786656 ·Status: COMPLETED
-
Increasing Germline Genetic Testing for Patients With Cancer
NCT07307664 ·Status: RECRUITING ·Phase: NA
-
Integrated Molecular Profiling in Advanced Cancers Trial
NCT01505400 ·Status: ACTIVE_NOT_RECRUITING
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Integrated Cancer Repository for Cancer Research
NCT02012699 ·Status: RECRUITING